Digital Therapeutics R&D

A leading DTx co-dev partner

We offer end-to-end DM & DTx co-dev partnerships

We are an entrepreneurial and multi-disciplinary team of digital health experts, behavioral designers, clinical researchers, software engineers, and data scientists with a track record of successful co-development partnerships with pharmas and startups.
Putting patient needs at the core of all our products, our methodology defines DTx and Digital Medicines products through a rigorous scientific analysis, commercial sustainability potential and strategic market fit.
All of our solutions are created exclusively in-house by our technical team, and proof of concepts and MVPs development is accelerated thanks to our partner DTx platform (H.Core).
Our capabilities and innovation offerings are augmented by an evolving "partner-ready" DTx solutions pipeline with some of our products having already reached full clinical validation.
We also maintain an evergreen Digital Health innovation offering, seeking out novel solutions in all therapeutic areas via our Healthware Ventures arm, and by investing in the acceleration of promising new startups.

BLOG

13/09/2023 | BlogPost

Leveraging Data Science in R&D: Integrating Data Silos to Generate High-Value Insights

The opportunity for Data Science and Big Data in life sciences is particularly compelling within complex corporate environments that face an ever-growing volume and diversity of information.

26/04/2023 | Booklet

Download the booklet "Innovation as Strategy: Enabling life sciences of the future"

An exploration of our Innovation as Strategy mindset and way of working that drives us in supporting our clients’ businesses

12/04/2023 | BlogPost

When will “digital health” just become health?

Despite the significant drop in funding in 2022, digital health is here to stay. 

28/03/2023 | Booklet

Download the Expert Opinion on "Digital Therapeutics to enhance the care pathways for depression across the national health service: expert proposals for Italy”

The document reports five expert proposals and a possible clinical-organizational process for the integration of Digital Therapeutics across depression care pathways in the Italian national health service